Journal article
The differential effects of CBD and CBDA on viability and mRNA expression in colorectal cancer cells
Journal of cannabis research, v 8(1), 24
16 Jan 2026
PMID: 41546069
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
BackgroundCannabinoids have attracted significant attention for their potential therapeutic application in cancer research. However, recent studies have reported antitumor activity of cannabidiolic acid (CBDA)-the acidic precursor of CBD-in breast cancer cells, involving modulation of cyclooxygenase signaling. To our knowledge, no investigations have examined the effects of CBDA on RNA expression and signaling pathways in colorectal cancer (CRC) cells. Therefore, we aimed to investigate the effects of CBD, CBDA, and a CBDA-rich Cannabis sativa (C.s). extract on the growth and gene expression in CRC cell lines.MethodsWe assessed cell viability and clonogenic growth of the CRC cell lines HCT116 and DLD1 following treatment with pure CBD, pure CBDA, a CBDA-rich C.s. extract (CBDA/CBD ratio 20:1), and a corresponding mixture of pure CBDA/CBD. RNA sequencing was performed to analyze differentially expressed genes (DEGs) and the cell signaling pathways affected by these treatments.ResultsOf all tested compounds, CBD exhibited the strongest cytotoxic effect in both cell lines, whereas CBDA demonstrated minimal toxicity, particularly in HCT116 cells. Furthermore, we observed a greater inhibitory effect of the CBDA-rich C.s. extract on HCT116 cell growth compared to the CBDA/CBD mixture. RNA sequencing analysis revealed that CBD had the most pronounced impact on gene expression, while CBDA had the least. Notably, treatment with the C.s. extract resulted in a higher number of DEGs than the CBDA/CBD mixture in HCT116. Gene expression analysis indicated an upregulation of the Wnt and Hippo signaling pathways following CBD treatment. Additionally, CBDA, CBD/CBDA (1:20), and the C.s. extract primarily induced metabolic processes in DLD1 cells, suggesting a distinct metabolic response.ConclusionOur findings showed that CBD exerts stronger effects on cell survival and gene expression in CRC cells than CBDA, which showed only limited activity. Moreover, the CBDA-rich C.s. extract exhibited greater efficacy than the CBDA/CBD mixture. More research is needed to further elucidate the impact of cannabinoids on CRC cell biology and signaling pathways.
Metrics
1 Record Views
Details
- Title
- The differential effects of CBD and CBDA on viability and mRNA expression in colorectal cancer cells
- Creators
- Christine Heinzle - Vorarlberg Institute for Vascular Investigation and TreatmentKathrin Geiger - Vorarlberg Institute for Vascular Investigation and TreatmentReinhard Ertl - University of Veterinary Medicine ViennaEva Maria Brandtner - Vorarlberg Institute for Vascular Investigation and TreatmentAndreas Leiherer - Private University in the Principality of LiechtensteinStella Gaenger - Vorarlberg Institute for Vascular Investigation and TreatmentDavid Schmidmayr - Lauder Business SchoolHeinz Drexel - Vorarlberg Institute for Vascular Investigation and TreatmentAxel Muendlein - Vorarlberg Institute for Vascular Investigation and Treatment
- Publication Details
- Journal of cannabis research, v 8(1), 24
- Publisher
- Springer Nature
- Number of pages
- 17
- Grant note
- 52118651 / sterreichische Forschungsfrderungsgesellschaft
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Medicine
- Web of Science ID
- WOS:001687355700001
- Scopus ID
- 2-s2.0-105029808466
- Other Identifier
- 991022196570704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
Source: SDGs in the Output
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Pharmacology & Pharmacy